Prebet T, Fenaux P, Vey N. Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system. Haematologica [Internet]. 2016Sep.30 [cited 2026Nov.13];101(10):e427-e428. Available from: https://haematologica.org/article/view/7864